Insulin-Like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-2040
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Validation of the Type 1 Insulin-Like Growth Factor Receptor as a Therapeutic Target in Renal Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Insulin-Like Growth Factor Receptor Type I as a Target for Cancer Therapy

Frontiers in Bioscience - Scholar
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2013English

Lin28b Promotes Head and Neck Cancer Progression via Modulation of the Insulin-Like Growth Factor Survival Pathway

Oncotarget
Oncology
2012English

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Insulin-Like Growth Factor Receptor Signaling in Thyroid Cancers: Clinical Implications and Therapeutic Potential

2012English

Grp78 as a Therapeutic Target for Refractory Head–neck Cancer With CD24−CD44+ Stemness Phenotype

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2013English

Type 1 Insulin-Like Growth Factor Receptor Targeted Therapies in Pediatric Cancer

Frontiers in Oncology
Cancer ResearchOncology
2013English

Expression and Growth Dependency of the Insulin-Like Growth Factor I Receptor in Craniopharyngioma Cells: A Novel Therapeutic Approach

Clinical Cancer Research
Cancer ResearchOncology
2005English

The Insulin-Like Growth Factor System in Cancer

Endocrinology and Metabolism Clinics of North America
EndocrinologyMetabolismDiabetes
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy